.

Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics

Post-transplant diabetes mellitus (PTDM) is a common problem after kidney transplantation (KT). The clinical importance of PTDM depends on its impact as a significant risk factor for cardiovascular and chronic kidney disease (CKD) post solid organ transplantation. Updated treatment guidelines of Kidney Disease: Improving Global Outcomes (KDIGO) has put light on the newer antidiabetic agents for diabetes management in CKD. Hence, Nuria Montero and colleagues published a research paper in the Clinical Kidney Journal under the title “Management of post-transplant diabetes mellitus: an opportunity for novel therapeutics”. The summary of this paper is given below:

Objective:

To evaluate and provide guidance on DM management in KT recipients.

Method:

The research paper was developed from the currently available evidence and scientific and medical knowledge.

Findings:

Intensive blood glucose monitoring and flexible and safe treatment algorithms are required in PTDM patients due to rapidly changing conditions.

Incretin Agents

A)Glucagon-like peptide-1 receptor agonists (GLP-1 RA)

Renal Benefits: some studies show that GLP-1 RA delays reduction in eGFR levels and decreases albuminuria. These findings need validation.
Cardiovascular Benefits: While there is a need for further research, GLP-1RA may decrease cardiovascular events.
Metabolic Impact: GLP-1RA increase insulin secretion and decrease glucagon secretion, with better glycemic control. It also helps in weight loss.

B)Dipeptidyl peptidase-4 inhibitors (DPP4i)

Renal Benefits: It was found to decrease albuminuria in some studies.
Metabolic Impact: DPP4i helps in decreasing insulin resistance and β-cell dysfunction. It decreases insulin requirements and improves glycemic control. Helps in Weight loss.

C)Sodium-Glucose Co-transporter 2 (SGLT2i)

Renal Benefits: It may decrease hyperfiltration and albuminuria.
Cardiovascular Benefits: It may decrease systolic blood pressure.
Metabolic Impact: It helps in weight loss.

Image Credit : Medical photo created by wavebreakmedia_micro – www.freepik.com

Afshin Sayyed

Afshin Sayyed joined Zandra Healthcare as an Editor in 2020. She has completed her Bachelor's in Nutrition and Dietetics from SNDT (Shreemati Nathibai Damodar Thackersey Women's) University. She has completed her PG Diploma in Clinical Nutrition and Dietetics from Mumbai University. She is a Certified Diabetes Educator and Content Writer. She has experience in Community Nutrition and other fieldwork with NGO's as well as corporate sectors.

You may also like...